Jane Street Group LLC bought a new position in shares of Aterian, Inc. (NASDAQ:ATER – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 11,380 shares of the company’s stock, valued at approximately $33,000. Jane Street Group LLC owned 0.13% of Aterian at the end of the most recent reporting period.
Separately, Essex Investment Management Co. LLC bought a new position in shares of Aterian during the 3rd quarter worth approximately $102,000. Institutional investors own 7.02% of the company’s stock.
Aterian Stock Down 4.3 %
NASDAQ:ATER opened at $2.24 on Friday. Aterian, Inc. has a twelve month low of $1.90 and a twelve month high of $6.54. The company has a fifty day moving average of $2.50 and a 200-day moving average of $2.79. The firm has a market capitalization of $19.62 million, a P/E ratio of -0.82 and a beta of 2.06.
About Aterian
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
Recommended Stories
- Five stocks we like better than Aterian
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- P/E Ratio Calculation: How to Assess Stocks
- Micron Technology: Riding the AI Wave to Long-Term Growth
Want to see what other hedge funds are holding ATER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aterian, Inc. (NASDAQ:ATER – Free Report).
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.